204 related articles for article (PubMed ID: 19019998)
1. Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate.
Muntner P; Jones TM; Hyre AD; Melamed ML; Alper A; Raggi P; Leonard MB
Clin J Am Soc Nephrol; 2009 Jan; 4(1):186-94. PubMed ID: 19019998
[TBL] [Abstract][Full Text] [Related]
2. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 23 and fetuin A are independent predictors for the coronary artery disease extent in mild chronic kidney disease.
Kanbay M; Nicoleta M; Selcoki Y; Ikizek M; Aydin M; Eryonucu B; Duranay M; Akcay A; Armutcu F; Covic A
Clin J Am Soc Nephrol; 2010 Oct; 5(10):1780-6. PubMed ID: 20576822
[TBL] [Abstract][Full Text] [Related]
4. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD.
Kooienga L; Fried L; Scragg R; Kendrick J; Smits G; Chonchol M
Am J Kidney Dis; 2009 Mar; 53(3):408-16. PubMed ID: 19185400
[TBL] [Abstract][Full Text] [Related]
5. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
Vassalotti JA; Uribarri J; Chen SC; Li S; Wang C; Collins AJ; Calvo MS; Whaley-Connell AT; McCullough PA; Norris KC;
Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S56-68. PubMed ID: 18359409
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 23 (FGF23) and early chronic kidney disease in the elderly.
Chudek J; Kocełak P; Owczarek A; Bożentowicz-Wikarek M; Mossakowska M; Olszanecka-Glinianowicz M; Wiecek A
Nephrol Dial Transplant; 2014 Sep; 29(9):1757-63. PubMed ID: 24729016
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease.
Lishmanov A; Dorairajan S; Pak Y; Chaudhary K; Chockalingam A
Int Urol Nephrol; 2012 Apr; 44(2):541-7. PubMed ID: 21327525
[TBL] [Abstract][Full Text] [Related]
8. Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4.
Coburn JW; Maung HM; Elangovan L; Germain MJ; Lindberg JS; Sprague SM; Williams ME; Bishop CW
Am J Kidney Dis; 2004 May; 43(5):877-90. PubMed ID: 15112179
[TBL] [Abstract][Full Text] [Related]
9. Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study.
Navarro-González JF; Mora-Fernández C; Muros M; Herrera H; García J
Clin J Am Soc Nephrol; 2009 Oct; 4(10):1646-54. PubMed ID: 19808245
[TBL] [Abstract][Full Text] [Related]
10. Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
Portale AA; Booth BE; Halloran BP; Morris RC
J Clin Invest; 1984 Jun; 73(6):1580-9. PubMed ID: 6547151
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
Levin A; Bakris GL; Molitch M; Smulders M; Tian J; Williams LA; Andress DL
Kidney Int; 2007 Jan; 71(1):31-8. PubMed ID: 17091124
[TBL] [Abstract][Full Text] [Related]
12. Abnormal Diurnal Patterns of Parathyroid Hormone are Associated with Sustained Mild Hypercalcemia in Non-Dialyzed Chronic Kidney Disease.
Yamato M; Takaori K; Tomiyama Y; Fujimura R; Yokobatake C; Wada A; Ito T
Clin Lab; 2016; 62(1-2):81-8. PubMed ID: 27012036
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum anion gap in adults with moderate chronic kidney disease increases risk for progression to end-stage renal disease.
Banerjee T; Crews DC; Wesson DE; McCulloch CE; Johansen KL; Saydah S; Rios Burrows N; Saran R; Gillespie B; Bragg-Gresham J; Powe NR
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1244-F1253. PubMed ID: 30908932
[TBL] [Abstract][Full Text] [Related]
14. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of anemia and serum iPTH, calcium, and phosphorus in patients with primary glomerulonephritis.
Li Y; Zhang W; Ren H; Wang W; Shi H; Li X; Chen X; Shen P; Wu X; Xie J; Chen N
Contrib Nephrol; 2013; 181():31-40. PubMed ID: 23689565
[TBL] [Abstract][Full Text] [Related]
16. Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.
Jungert A; Neuhäuser-Berthold M
Nutr Res; 2013 Aug; 33(8):661-7. PubMed ID: 23890356
[TBL] [Abstract][Full Text] [Related]
17. The prevalence and detection of chronic kidney disease (CKD)-related metabolic complications as a function of estimated glomerular filtration rate in the oldest old.
Van Pottelbergh G; Vaes B; Jadoul M; Matheï C; Wallemacq P; Degryse JM
Arch Gerontol Geriatr; 2012; 54(3):e419-25. PubMed ID: 22265240
[TBL] [Abstract][Full Text] [Related]
18. Factors related with the progression of chronic kidney disease.
Yuste C; Barraca D; Aragoncillo-Sauco I; Vega-Martínez A; Abad S; Verdalles-Guzmán Ú; Ruiz-Caro C; Ampuero J; López-Gómez JM
Nefrologia; 2013; 33(5):685-91. PubMed ID: 24089160
[TBL] [Abstract][Full Text] [Related]
19. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL
Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826
[TBL] [Abstract][Full Text] [Related]
20. Serum magnesium, bone-mineral metabolism markers and their interactions with kidney function on subsequent risk of peripheral artery disease: the Atherosclerosis Risk in Communities Study.
Menez S; Ding N; Grams ME; Lutsey PL; Heiss G; Folsom AR; Selvin E; Coresh J; Jaar BG; Matsushita K
Nephrol Dial Transplant; 2020 Nov; 35(11):1878-1885. PubMed ID: 32191294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
